RYAN

Ryan Specialty Holdings Inc

Add to Watchlist

Advanced Chart

58.490

-1.06(-1.780%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

59.790

Open

59.540

VWAP

58.55

Vol

1.34M

Mkt Cap

15.42B

Low

58.020

Amount

78.75M

EV/EBITDA(TTM)

21.99

Total Shares

119.06M

19.58B

EV/OCF(TTM)

34.26

P/S(TTM)

4.22

Ryan Specialty Holdings, Inc. is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter with delegated authority from insurance carriers. For retail insurance brokers, it assists in the placement of complex or otherwise hard-to-place risks. For insurance carriers, it works with retail and wholesale insurance brokers to source, onboard, underwrite, and service these same risks. It Wholesale Brokerage Specialty operates under the brand RT Specialty along with others, such as RT ProExec and CERT. Its Binding Authority Specialty operates under the RT Specialty and RT Binding Authority brands. Its Underwriting Management Specialty operates under multiple brands, which are collectively referred to as Ryan Specialty Underwriting Managers. It also specializes in builder's risk insurance.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

800.67M

+16.01%

0.499

+27.97%

784.52M

+18.23%

0.532

+18.2%

742.35M

+22.77%

0.482

+17.57%

Estimates Revision

The market is revising Upward the revenue expectations for Ryan Specialty Holdings, Inc. (RYAN) for FY2025, with the revenue forecasts being adjusted by 0.15% over the past three months. During the same period, the stock price has changed by -16.11%.

Revenue Estimates for FY2025

Revise Upward

+0.15%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-1.23%

In Past 3 Month

Stock Price

Go Down

-16.11%

In Past 3 Month

9 Analyst Rating

29.70% Upside

Wall Street analysts forecast RYAN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RYAN is 75.86 USD with a low forecast of 63.00 USD and a high forecast of 89.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

7 Buy

1 Hold

1 Sell

Moderate Buy

29.70% Upside

Current: 58.490

Low

63.00

Averages

75.86

High

89.00

29.70% Upside

Current: 58.490

Low

63.00

Averages

75.86

High

89.00

UBS

Buy

downgrade

$84 -> $80

2025-08-04

New

Reason

UBS

Price Target

$84 -> $80

2025-08-04

New

downgrade

Buy

Reason

UBS lowered the firm's price target on Ryan Specialty to $80 from $84 and keeps a Buy rating on the shares. The firm updated its model for Property & Casualty and Brokers. UBS cites lower premiums and margins for the price target update.

Morgan Stanley

Overweight

downgrade

$80 -> $78

2025-07-14

Reason

Morgan Stanley

Price Target

$80 -> $78

2025-07-14

downgrade

Overweight

Reason

Morgan Stanley lowered the firm's price target on Ryan Specialty to $78 from $80 and keeps an Overweight rating on the shares.

Wells Fargo

Equal Weight

downgrade

$65 -> $63

2025-07-10

Reason

Wells Fargo

Price Target

$65 -> $63

2025-07-10

downgrade

Equal Weight

Reason

Wells Fargo lowered the firm's price target on Ryan Specialty to $63 from $65 and keeps an Equal Weight rating on the shares ahead of quarterly results. The firm says the focus should be on pricing, loss trend, and reserves for P&C companies, organic and margin for brokers, and sales/VII/capital for life companies.

Barclays

Alex Scott

Overweight

downgrade

$83 -> $79

2025-07-07

Reason

Barclays

Alex Scott

Price Target

$83 -> $79

2025-07-07

downgrade

Overweight

Reason

Barclays analyst Alex Scott lowered the firm's price target on Ryan Specialty to $79 from $83 and keeps an Overweight rating on the shares. Heading into Q2 earnings, the firm is more cautious on property and casualty carriers, saying underwriting margins face pressure from softening rates and unfavorable mix shift. Barclays is more constructive on reinsurers due to "idiosyncratic tailwinds" and capital return potential in the second half of the year. The analyst names Everest Group (EG) and Hartford Insurance (HIG) as top ideas.

Morgan Stanley

Bob Huang

Overweight

maintain

$78 -> $80

2025-05-19

Reason

Morgan Stanley

Bob Huang

Price Target

$78 -> $80

2025-05-19

maintain

Overweight

Reason

Morgan Stanley analyst Bob Huang raised the firm's price target on Ryan Specialty to $80 from $78 and keeps an Overweight rating on the shares. The firm is updating its price targets on stocks under its coverage in the P&C Insurance sector, the analyst tells investors. Results were somewhat mixed depending on the segments, but the firm sees further growth and margin expansion in personal lines, which should be durable in 2025. Heading into 2025, the firm expects broader P&C trend to remain steady, with personal lines and brokers leading on the earnings growth front.

Goldman Sachs

Neutral -> Buy

upgrade

$74 -> $81

2025-05-13

Reason

Goldman Sachs

Price Target

$74 -> $81

2025-05-13

upgrade

Neutral -> Buy

Reason

Goldman Sachs upgraded Ryan Specialty to Buy from Neutral with a price target of $81, up from $74. The company will offer the greatest organic growth, total revenue growth, and margin expansion opportunity in the insurance brokerage coverage universe over the next several years, with a "reasonable valuation considering better-than-peer fundamentals," the analyst tells investors in a research note. The firm expects investors to be forward-looking to the second half of 2025 and beyond, where it believes Ryan can maintain its organic growth gap versus retail insurance brokers.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Ryan Specialty Holdings Inc (RYAN.N) is 25.58, compared to its 5-year average forward P/E of 30.76. For a more detailed relative valuation and DCF analysis to assess Ryan Specialty Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

30.76

Current PE

25.58

Overvalued PE

33.43

Undervalued PE

28.09

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

10.80

Current EV/EBITDA

10.71

Overvalued EV/EBITDA

11.73

Undervalued EV/EBITDA

9.86

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

2.48

Current PS

2.31

Overvalued PS

2.75

Undervalued PS

2.21